Rapid Therapeutic Science Laboratories, Inc. Convertible Notes Payable, Current
Rapid Therapeutic Science Laboratories, Inc. had Convertible Notes Payable, Current of $2.46 million as of 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Notes and Loans Payable, Current › Notes Payable, Current
us-gaap:ConvertibleNotesPayableCurrent · last filed 2023-08-14
- 2023-06-30: Convertible Notes Payable, Current $2.46M.
- 2022-12-31: Convertible Notes Payable, Current $2.48M.
- 2021-12-31: Convertible Notes Payable, Current $1.10M.
- 2021-09-30: Convertible Notes Payable, Current $454.76K.
| Period end | Convertible Notes Payable, Current |
|---|---|
| 2023-06-30 | $2.46M 10-Q · filed 2023-08-14 |
| 2022-12-31 | $2.48M 10-Q · filed 2023-08-14 |
| 2021-12-31 | $1.10M 10-K · filed 2022-03-16 |
| 2021-09-30 | $454.76K 10-Q · filed 2021-11-10 |
| 2020-12-31 | $674.93K 10-K · filed 2022-03-16 |